<DOC>
	<DOCNO>NCT02396420</DOCNO>
	<brief_summary>The purpose study evaluate improvement symptom relate benign prostatic hyperplasia ( BPH ) men treat prostate artery embolization ( PAE ) use Embosphere Microspheres .</brief_summary>
	<brief_title>Prostate Artery Embolization Treatment Benign Prostatic Hyperplasia Men With Prostates Larger Than 90 Grams</brief_title>
	<detailed_description>The study evaluate improvement symptom associate benign prostatic hyperplasia ( BPH ) men prostates large 90 gram treat prostate artery embolization ( PAE ) . Symptoms assess utilizing International Prostate Symptom Score ( IPSS ) evaluate change baseline 12 month post PAE .</detailed_description>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<criteria>Patient provide sign informed consent Patient age great equal 40 less equal 89 year age Patient prostate size 90g 200g , determine MRI Patient experience low urinary tract symptom ( LUTS ) least 6 month prior study enrollment Patient IPSS score least 13 baseline Patient either : refractory medical treatment , contraindicate medical treatment , OR refuse medical treatment Patient either : refuse surgical treatment OR contraindicate surgical treatment Patient meet ONE follow criterion : baseline PSA &lt; 4.0ng/mL ( prostate biopsy require ) OR baseline PSA &gt; /= 4 ng/mL AND negative prostate biopsy ( minimum 12 core biopsy ) within prior 12 month History prostate , bladder , rectal cancer History transurethral resection prostate ( TURP ) , open prostate surgery , radiofrequency microwave therapy History open bladder , rectosigmoid colon , pelvic surgery Patient unwilling discontinue alpha blocker 1 month study treatment Patient unwilling discontinue 5alph reductase inhibitor 1 month study treatment Neurogenic bladder neurologic disorder impact bladder function Parkinson 's disease , multiple sclerosis , cerebral vascular accident diabetes Any confound bladder urethral pathology , include urethral stricture , bladder neck contracture , bladder atonia Active prostatitis urinary tract infection Cystolithiasis within past 3 month Serum creatinine &gt; 1.7mg/dL Inability discontinue oral anticoagulant 25 day prior study treatment Coagulation disturbances normalized medical treatment Iodinated contrast allergy , opinion Investigator , adequately premedicated Gelatin allergy Known severe peripheral vascular disease major iliac arterial occlusive disease Interest future fertility Clinically significant cardiac arrhythmia cardiac disease ( include congestive heart failure ) , uncontrolled diabetes mellitus , clinically significant respiratory disease , know immunosuppression Other condition Investigator believe put patient risk complication procedure</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>89 Years</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>BPH</keyword>
	<keyword>prostatic hyperplasia</keyword>
	<keyword>enlarge prostate</keyword>
	<keyword>benign prostatic hypertrophy</keyword>
</DOC>